Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ceribell, Inc.CBLL · Entity 4994 | Director | July 28, 2026 | July 30, 2026 |
| Covista Inc.ATGE · Entity 3964 | Director | November 12, 2025 | November 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ceribell, Inc.
Report date July 28, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,011 |
Reported balance
After 2026-07-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 16,011 · Balance 16,011 F1: Represents restricted stock units ("RSUs"). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs").
Covista Inc.
Report date November 12, 2025 · Filed November 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,597 |
Reported balance
After 2025-11-12 transaction · row 1
1 source rowRow 1 · 2025-11-12 · Grant · Acquired 1,445 · Balance 16,597 F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. F2: The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date.
F2: The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $96.86, the closing price of ATGE common stock on November 12, 2025.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Apollo Endosurgery, Inc.
Report date April 04, 2023 · Filed April 04, 2023
Section 16 reporting ended · disclosed 2023-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-04-04 transaction · row 1
1 source rowRow 1 · 2023-04-04 · Disposition to issuer · Disposed 35,604 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation ("Parent") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the "Merger"), at the effective time of the Merger (the "Effective Time"), each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an "Issuer RSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the right to receive $10.00 in cash, without interest (the "Merger Consideration"), less applicable taxes and authorized deduction [footnote continues in footnote 2 below] F2: and (2) the aggregate number of shares of Issuer common stock, par value $0.001 per share ("Issuer Common Stock") underlying such Issuer RSU, less applicable taxes and authorized deductions. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation ("Parent") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the "Merger"), at the effective time of the Merger (the "Effective Time"), each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an "Issuer RSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the right to receive $10.00 in cash, without interest (the "Merger Consideration"), less applicable taxes and authorized deduction [footnote continues in footnote 2 below]
F2: and (2) the aggregate number of shares of Issuer common stock, par value $0.001 per share ("Issuer Common Stock") underlying such Issuer RSU, less applicable taxes and authorized deductions.
VOCERA COMMUNICATIONS, INC.
Report date February 23, 2022 · Filed February 23, 2022
Section 16 reporting ended · disclosed 2022-02-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-15 · Gift · Disposed 1,900 · Balance 42,166 F1: Represents shares of the Issuer's common stock that the Reporting Person donated as a gift to a donor advised fund. Row 2 · 2022-02-23 · Disposition to issuer · Disposed 42,166 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the Issuer's common stock that the Reporting Person donated as a gift to a donor advised fund.
F2: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2022, by and among the Issuer, Stryker Corporation ("Stryker") and Voice Merger Sub Corp. ("Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Stryker, effective as of February 23, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the common stock was exchanged into the right to receive $79.25 in cash, without interest and less any applicable withholding taxes, at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2017 Filed Oct 10, 2017 16:25 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038048 · doc1.xml · derivative · entry 3 O'KEEFE SHARON · CIK 0001544333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,333 Underlying: Common Stock · 2,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The stock option grant is fully vested and immediately exercisable. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 16:25 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | SaleCommon Stock | 2,000 | $31.17 | $62,340.00 |
DisclosureSEC source: 0001140361-17-038048 · doc1.xml · nonDerivative · entry 2 O'KEEFE SHARON · CIK 0001544333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,127 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 16:25 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | Exercise / conversionCommon Stock | 2,000 | $16.00 | $32,000.00 |
DisclosureSEC source: 0001140361-17-038048 · doc1.xml · nonDerivative · entry 1 O'KEEFE SHARON · CIK 0001544333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:37 UTC | VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917 | GrantCommon Stock | 5,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-023697 · doc1.xml · nonDerivative · entry 1 O'KEEFE SHARON · CIK 0001544333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,127 F1 · shares: Represents a restricted stock unit award that vests in full on June 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.